首页> 美国卫生研究院文献>other >Cytotoxic Effect of Icaritin and Its Mechanisms in Inducing Apoptosis in Human Burkitt Lymphoma Cell Line
【2h】

Cytotoxic Effect of Icaritin and Its Mechanisms in Inducing Apoptosis in Human Burkitt Lymphoma Cell Line

机译:鹰嘴豆素的细胞毒作用及其诱导人伯基特淋巴瘤细胞凋亡的机制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Icaritin (ICT), a hydrolytic product of icariin from Epimedium genus, exhibits antitumor activities in several human solid-tumor and myeloid leukemia cells with extensive influence on various cell signal molecules, such as MAPKs being involved in cell proliferation and Bcl-2 participating in cell apoptosis. However, the effect of icaritin on Burkitt Lymphoma has not been elucidated. In the present study, we first screened the potential effect of icaritin on Burkitt lymphoma Raji and P3HR-1 cell lines and found that icaritin showed cytotoxicity in both cell lines. We further found that icaritin could significantly inhibit Raji cells proliferation with S-phase arrest of cell cycle and induced cell apoptosis accompanied by activation of caspase-8 and caspase-9 and cleavage of PARP. We also observed that icaritin was able to decrease Bcl-2 levels, thus shifting the Bcl-2/Bax ratio, and it could obviously reduce c-Myc, a specific molecular target in Burkitt lymphoma. Our findings demonstrated that icaritin showed cytotoxicity, inhibited cell growth, caused S arrest, and induced apoptosis in Burkitt lymphoma cells and provided a rationale for the further evaluation of icaritin for Burkitt lymphoma therapy.
机译:淫羊in素的水解产物伊卡肽素(ICT)在几种人类实体瘤和髓样白血病细胞中表现出抗肿瘤活性,对多种细胞信号分子产生广泛影响,例如参与细胞增殖的MAPK和参与Bcl-2的参与细胞凋亡。然而,尚未阐明依卡替丁对伯基特淋巴瘤的作用。在本研究中,我们首先筛选了icaritin对Burkitt淋巴瘤Raji和P3HR-1细胞系的潜在作用,并发现icaritin在两种细胞系中均显示出细胞毒性。我们进一步发现,icaritin可以显着抑制Raji细胞增殖,并伴随S期细胞周期停滞和诱导细胞凋亡,并伴有caspase-8和caspase-9的激活以及PARP的裂解。我们还观察到,icaritin能够降低Bcl-2水平,从而改变Bcl-2 / Bax比率,并且可以明显降低Burkitt淋巴瘤的特定分子靶标c-Myc。我们的研究结果表明,icaritin在Burkitt淋巴瘤细胞中显示出细胞毒性,抑制细胞生长,引起S阻滞并诱导凋亡,并为进一步评估icaritin用于Burkitt淋巴瘤治疗提供了依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号